Table 2.
Groups | Total fat pads weight (g) | Perirenal fat pads weight (g) | Epididymal fat pads weight (g) |
---|---|---|---|
NOR | 16.8 ± 2.6 a | 10.4 ± 1.4 ab | 8.3 ± 1.5 ab |
HF | 27.6 ± 3.5 c | 17.0 ± 3.9 d | 13.0 ± 1.5 d |
UPW-R-1X | 25.4 ± 7.0 bc | 14.9 ± 5.4 cd | 10.5 ± 1.9 c |
DOW-R-1X | 22.8 ± 4.1 b | 12.8 ± 2.7 bc | 9.8 ± 1.3 bc |
DOW-R-2X | 18.9 ± 2.2 a | 10.7 ± 1.5 ab | 8.5 ± 1.2 ab |
MS | 16.5 ± 2.8 a | 9.4 ± 1.6 a | 6.9 ± 1.2 a |
AK | 17.5 ± 2.5 a | 9.9 ± 1.4 ab | 6.9 ± 1.4 a |
NOR, normal diet (3.34 kcal/g); HF, high-fat diet (4.17 kcal/g); UPW-R-1X, UPW-RMD powder (1×, 27.81 mg/day 100 g bw) and high-fat diet; DOW-R-1X, DOW-RMD powder (1×, 27.81 mg/day 100 g bw) and high-fat diet; DOW-R-2X, DOW-RMD powder (2×, 55.62 mg/day 100 g bw) and high-fat diet; and high-fat diet; MS, monascin powder (2×, 0.152 mg/day 100 g bw) and high-fat diet; AK, ankaflavin powder (2×, 0.162 mg/day 100 g bw) and high-fat diet. Data are presented as means ± SD (n = 8). Mean values within each column with different superscripts are significant difference (p < 0.05).